Close Menu
iM.NewsiM.News

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    New Weight-Loss Drug Cuts Knee Pain in Half for OA Patients

    November 20, 2026

    Google to retire Nest app in January 2027

    November 20, 2026

    Rocky’s 50th Anniversary: The Underdog Best Picture Win

    November 20, 2026
    Facebook X (Twitter) Instagram
    iM.NewsiM.News
    Subscribe
    • Home
    • Lifestyle

      New Weight-Loss Drug Cuts Knee Pain in Half for OA Patients

      November 20, 2026

      Robert Pattinson and Suki Waterhouse Redefine Hollywood Power Couples

      November 20, 2026

      Reading Linked to 33% Lower Alzheimer’s Risk, Study Finds

      November 20, 2026

      Keto Diet Cuts Liver Fat by 67% in Clinical Trial

      November 20, 2026

      Man Turns In Fugitive Father After Learning He Killed a Child

      November 20, 2026
    • Relations

      Former US National Security Adviser Jake Sullivan Confronted by Students at MIT

      November 20, 2026

      Xi Jinping’s Restraint: The Power of Not Acting in Shenzhen

      November 20, 2026

      EU and UK to Sign Reset Deal on Trade and Youth Mobility

      November 20, 2026

      UK and EU to Agree Youth Mobility Scheme at Summit

      November 20, 2026

      White House Cyber Director Sean Cairncross Ousted After Tech Outages

      November 20, 2026
    • Technology

      Google to retire Nest app in January 2027

      November 20, 2026

      Microsoft Link to Windows Adds Second Screen Feature

      November 20, 2026

      Nothing Sets December 8 Date for AI Hardware Reveal

      November 20, 2026

      iPhone Air 2 Dummy Unit Reveals Dual-Camera Upgrade

      November 20, 2026

      OpenAI AI Boosts AMD GPU Design by 14 Percent

      November 20, 2026
    • Travel & Tourism

      Oil Spills Threaten UAE and Oman Beaches Amid Hormuz Conflict

      November 20, 2026

      Aer Lingus to Retrofit A330 Fleet with Premium Economy and New Business Class

      November 20, 2026

      Sabre Targets AI Travel Bookings With New Connector

      November 20, 2026

      Riyadh Hotel Revenue Plummets 65% After Airport Attack

      November 20, 2026

      JetBlue Adds Grand Cayman and Honduras Routes From Fort Lauderdale

      November 20, 2026
    • Get in Touch
    iM.NewsiM.News
    Home»Lifestyle»Health»New Weight-Loss Drug Cuts Knee Pain in Half for OA Patients
    Health

    New Weight-Loss Drug Cuts Knee Pain in Half for OA Patients

    im.newsBy im.newsNovember 20, 2026No Comments3 Mins Read1 Views
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Medical illustration of retatrutide injection reducing knee osteoarthritis pain
    Share
    Facebook Twitter LinkedIn Pinterest WhatsApp Email

    For millions of Americans living with painful knee osteoarthritis, everyday movements like climbing stairs or standing up from a chair can be excruciating. Excess body weight places additional stress on these joints, worsening the condition. Two major phase 3 clinical trials led by Northwestern University suggest that retatrutide, an experimental injectable weight-loss medication, offers substantial relief for these patients.

    Published in the New England Journal of Medicine on November 8, the studies involved more than 1,000 participants. The results indicate that patients receiving the highest dose of retatrutide lost an average of 25% of their body weight. When researchers combined data from both trials, they found that approximately two-thirds of participants treated with the drug reported a reduction in knee pain of at least 50%. In contrast, only 38% of those given a placebo experienced similar relief.

    Retatrutide Knee Pain Reduction and Weight Loss

    Retatrutide is developed by Eli Lilly and administered as a once-weekly injection. It differs from existing GLP-1 medications like semaglutide and tirzepatide by activating receptors associated with three different naturally occurring hormones. While other drugs in this class typically produce weight reductions of 10% to 20%, retatrutide achieved reductions of 20% to 25% depending on the dosage.

    Dr. Thomas Schnitzer, a professor at Northwestern University Feinberg School of Medicine and the study’s corresponding author, noted that the findings highlight a clear connection between weight loss and pain relief. “The findings are really saying for people who are overweight and have OA, if you lose a significant amount of weight with this treatment, there is a good chance that you’re going to get a meaningful reduction in your knee pain,” Schnitzer said. He added that reducing the load on the knees allows patients to increase their physical function.

    Beyond pain and weight metrics, participants also showed improvements in blood pressure, blood lipid levels, and systemic inflammation. These results were presented by Philip Conaghan, a study co-author from the University of Leeds, at the American College of Rheumatology annual meeting in Orlando, Florida.

    Limitations and Future Research Directions

    Knee osteoarthritis affects approximately 15 million Americans, or 5% of the population. Current treatments range from physical therapy and topical medications to oral anti-inflammatories and corticosteroid injections. While lifestyle changes such as diet and exercise can help, losing more than 10% of body weight through these methods alone is often difficult, especially for individuals whose pain limits their ability to exercise.

    Schnitzer emphasized that lifestyle modifications should remain the first line of defense. These strategies avoid the side effects associated with GLP-1 drugs, which can include gastrointestinal issues and muscle loss. Maintaining muscle strength is critical for knee osteoarthritis patients, as the muscles surrounding the joint provide essential support and stability.

    Several questions remain unanswered regarding the long-term impact of retatrutide. Researchers do not yet know if the drug slows the underlying progression of osteoarthritis or reduces the likelihood of needing knee replacement surgery. Individuals who had already required knee replacements were excluded from the trials. Additionally, it is unclear whether the drug benefits patients with knee osteoarthritis who are not overweight, as these individuals were not included in the study.

    Scientists are also investigating how much of the pain relief stems directly from weight loss versus the drug’s anti-inflammatory properties. “Whether cutting down inflammation in the joint is also important in addition to reducing load needs more research,” Schnitzer said. The study utilized the Western Ontario and McMaster Universities Arthritis Index (WOMAC) Pain index to evaluate symptom changes, with participants recording daily pain levels via a mobile app.

    Source: ScienceDaily

    Clinical Trials Eli Lilly Health knee pain osteoarthritis retatrutide weight loss
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleGoogle to retire Nest app in January 2027
    im.news

    Related Posts

    Google to retire Nest app in January 2027

    November 20, 2026

    Rocky’s 50th Anniversary: The Underdog Best Picture Win

    November 20, 2026

    Former US National Security Adviser Jake Sullivan Confronted by Students at MIT

    November 20, 2026
    Leave A Reply Cancel Reply

    Latest Posts

    New Weight-Loss Drug Cuts Knee Pain in Half for OA Patients

    November 20, 20261 Views

    Google to retire Nest app in January 2027

    November 20, 20261 Views

    Rocky’s 50th Anniversary: The Underdog Best Picture Win

    November 20, 20262 Views

    Former US National Security Adviser Jake Sullivan Confronted by Students at MIT

    November 20, 20264 Views
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    Don't Miss

    Epstein List Phase 1: Full Flight Logs, Client List Released

    February 28, 2025 News Focus 247 Views

    In a stunning development that has sent shockwaves through political and entertainment circles, Attorney General…

    Microsoft Stock Joins Exclusive $4 Trillion Club After Blockbuster Cloud + AI Earnings

    July 31, 2025

    DOJ & FBI Find No Epstein Client List, Suicide Confirmed

    July 7, 2025

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    About Us
    About Us

    We provide the daily life news. You find latest trendy news at our portal, from entertainment to economy or politics.

    We're accepting new partnerships right now.

    Email Us: info@im.news

    Facebook X (Twitter) RSS
    Our Picks

    New Weight-Loss Drug Cuts Knee Pain in Half for OA Patients

    November 20, 2026

    Google to retire Nest app in January 2027

    November 20, 2026

    Rocky’s 50th Anniversary: The Underdog Best Picture Win

    November 20, 2026
    Most Popular

    Epstein List Phase 1: Full Flight Logs, Client List Released

    February 28, 2025247 Views

    Microsoft Stock Joins Exclusive $4 Trillion Club After Blockbuster Cloud + AI Earnings

    July 31, 2025208 Views

    DOJ & FBI Find No Epstein Client List, Suicide Confirmed

    July 7, 2025165 Views
    © 2026 I'm News. Designed by I'm News.
    • Home
    • Lifestyle
    • Relations
    • Travel & Tourism
    • Technology

    Type above and press Enter to search. Press Esc to cancel.